Myelodysplastic syndrome

Myelodysplastic syndrome (MDS) is primarily a disease of older adults. Can present with symptoms of anemia, leukopenia, and thrombocytopenia, but often found during routine laboratory investigations in asymptomatic patients.

Diagnosed when bone marrow demonstrates significant dysplasia, clonal cytogenetic abnormality, quantitative changes in at least one of the blood cell lines, and blasts <20%.

Treatment is often based on supportive measures, including red cell and platelet transfusions. Chemotherapy agents such as azacitidine, lenalidomide, and decitabine are used for certain patients. Stem cell transplant is the only potentially curative therapy.

May have a prolonged course with anemia and neutropenic infections, or may progress rapidly to acute myelogenous leukemia (AML). However, most patients die of infection while in the MDS stage of their disease.

Myelodysplastic syndrome (MDS) is a group of clonal stem cell disorders characterized by ineffective and dysplastic hematopoiesis resulting in one or more cytopenias, and a varying predilection to develop acute myeloid leukemia (AML).[1]Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 May 19;127(20):2391-405. https://ashpublications.org/blood/article/127/20/2391/35255/The-2016-revision-to-the-World-Health-Organization http://www.ncbi.nlm.nih.gov/pubmed/27069254?tool=bestpractice.com MDS is diagnosed when bone marrow demonstrates significant dysplasia, clonal cytogenetic abnormality, quantitative changes in at least one of the blood cell lines, and blasts <20%. Biologic features are more important than a strict blast cutoff value.[2]National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: myelodysplastic syndromes [internet publication]. https://www.nccn.org/guidelines/category_1 Patients with blasts ≥20% can be considered to have AML. MDS can arise primarily without any inciting event or may be related to previous treatment with either chemotherapy or radiation.